Medytox Inc.
Overview
History
R&D
Global Network
Global Network

Medytox has successfully developed a botulinum toxin biopharmaceutical, the fourth of its kind in the world, and is expanding along with the global biotech industry.

The company not only does business in the domestic market but also dvanced into over 50 countries, particularly in the regions of Asia, Europe and America. It is currently working with various partners in the global market and is leading the global biotechnology industry.

The company has completed product registrations in about 25 countries as of the end of 2012, and product registration is currently in progress in about 30 other countries.

Medytox Mini Poll

Which area do your patients most want to be treated with Neuronox?
a. Glabellar lines
b. Crow’s feet
c. Forehead lines
d. Masseter
e. Calf
MoreMedytox News